We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLS
3001
DELISTED
Regulus Therapeutics
RGLS
– –
-5,169
Closed -$81K
RHI icon
3002
Robert Half
RHI
$4.37B
– –
-168,403
Closed -$13.1M
RITM icon
3003
Rithm Capital
RITM
$5.69B
– –
-38,368
Closed -$432K
RKLB icon
3004
Rocket Lab Corp
RKLB
$51.8B
– –
-17,733
Closed -$210K
RKT icon
3005
Rocket Companies
RKT
$38.9B
– –
-260,260
Closed -$6.01M
RLX icon
3006
RLX Technology
RLX
$2.46B
– –
-32,792
Closed -$340K
RNG icon
3007
RingCentral
RNG
$5.28B
– –
-10,648
Closed -$3.17M
RPM icon
3008
RPM International
RPM
$15B
– –
-113,543
Closed -$10.4M
RRGB icon
3009
Red Robin
RRGB
$152M
– –
-31,341
Closed -$1.25M
RYTM icon
3010
Rhythm Pharmaceuticals
RYTM
$7.96B
– –
-178,757
Closed -$3.8M
SAR icon
3011
Saratoga Investment
SAR
$322M
– –
-23,832
Closed -$603K
FLNA
3012
Filana Therapeutics
FLNA
$48.1M
– –
-195,942
Closed -$8.81M
SBAC icon
3013
SBA Communications
SBAC
$19.5B
– –
-2,179
Closed -$605K
SBUX icon
3014
CALL
Starbucks
SBUX
$120B
– –
-14,500
Closed -$1.58M
SCHG icon
3015
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
– –
-16,640
Closed -$270K
SCHW
3016
Charles Schwab
SCHW
$187B
– –
-103,260
Closed -$6.73M
SDGR icon
3017
Schrodinger
SDGR
$1.36B
– –
-29,298
Closed -$2.23M
SEB icon
3018
Seaboard Corp
SEB
$4.06B
– –
-244
Closed -$900K
SEE
3019
DELISTED
Sealed Air
SEE
– –
-15,015
Closed -$688K
SEED icon
3020
Origin Agritech
SEED
$12.6M
– –
-11,288
Closed -$192K
SHC icon
3021
Sotera Health
SHC
$5.38B
– –
-184,867
Closed -$4.61M
SHYF
3022
DELISTED
The Shyft Group
SHYF
– –
-34,650
Closed -$1.29M
SIBN icon
3023
SI-BONE Inc
SIBN
$834M
– –
-7,119
Closed -$226K
SIGA icon
3024
SIGA Technologies
SIGA
$219M
– –
-17,987
Closed -$117K
SIGI icon
3025
Selective Insurance
SIGI
$5.73B
– –
-5,623
Closed -$408K
119 120
121
122 123

Similar funds

VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.